Schrodinger (SDGR) | Financial Analysis & Statements
Schrodinger Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
87.2M
Gross Profit
57.3M
65.68%
Operating Income
-17.2M
-19.67%
Net Income
32.5M
37.27%
Balance Sheet Metrics
Total Assets
726.2M
Total Liabilities
362.1M
Shareholders Equity
364.1M
Debt to Equity
0.99
Cash Flow Metrics
Operating Cash Flow
16.3M
Free Cash Flow
-16.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Schrodinger Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 255.9M | 207.5M | 216.7M | 181.0M | 137.9M |
| Cost of Goods Sold | 113.3M | 75.5M | 76.0M | 79.9M | 72.3M |
| Gross Profit | 142.6M | 132.1M | 140.7M | 101.0M | 65.6M |
| Gross Margin % | 55.7% | 63.6% | 64.9% | 55.8% | 47.6% |
| Operating Expenses | |||||
| Research & Development | 173.1M | 201.8M | 181.8M | 126.4M | 90.9M |
| Selling, General & Administrative | 136.4M | 139.6M | 136.4M | 121.5M | 86.2M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 309.5M | 341.4M | 318.1M | 247.8M | 177.1M |
| Operating Income | -166.9M | -209.3M | -177.4M | -146.8M | -111.4M |
| Operating Margin % | -65.2% | -100.8% | -81.9% | -81.1% | -80.8% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | 1.1M |
| Interest Expense | - | - | - | - | - |
| Other Non-Operating Income | 64.6M | 23.6M | 220.4M | -2.3M | 10.6M |
| Pre-tax Income | -102.3M | -185.7M | 42.9M | -149.1M | -100.8M |
| Income Tax | 939.0K | 1.4M | 2.2M | 63.0K | 411.0K |
| Effective Tax Rate % | 0.0% | 0.0% | 5.1% | 0.0% | 0.0% |
| Net Income | -103.3M | -187.1M | 40.7M | -149.2M | -101.2M |
| Net Margin % | -40.4% | -90.2% | 18.8% | -82.4% | -73.4% |
| Key Metrics | |||||
| EBITDA | -209.0M | -208.8M | -225.4M | -124.4M | -120.0M |
| EPS (Basic) | $-1.41 | $-2.57 | $0.57 | $-2.10 | $-1.42 |
| EPS (Diluted) | $-1.41 | $-2.57 | $0.54 | $-2.10 | $-1.42 |
| Basic Shares Outstanding | 73443298 | 72670295 | 71776301 | 71173419 | 70594950 |
| Diluted Shares Outstanding | 73443298 | 72670295 | 71776301 | 71173419 | 70594950 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Schrodinger Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 230.5M | 147.3M | 155.3M | 90.5M | 120.3M |
| Short-term Investments | 164.9M | 204.8M | 307.7M | 360.6M | 456.2M |
| Accounts Receivable | 83.0M | 235.7M | 66.0M | 56.0M | 31.7M |
| Inventory | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 519.3M | 635.0M | 567.8M | 534.0M | 625.1M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 114.0M | 122.8M | 127.1M | 106.1M | 75.4M |
| Goodwill | 9.6M | 9.6M | 9.6M | 10.2M | 0 |
| Intangible Assets | - | - | - | 587.0K | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 6.3M | 4.2M | 6.0M | 3.3M | 2.9M |
| Total Non-Current Assets | 206.9M | 188.2M | 235.2M | 154.6M | 131.4M |
| Total Assets | 726.2M | 823.2M | 803.0M | 688.6M | 756.5M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 11.5M | 10.7M | 16.8M | 9.5M | 8.1M |
| Short-term Debt | 16.4M | 16.8M | 16.9M | 11.0M | 2.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 189.1M | 191.7M | 133.7M | 108.8M | 91.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | 92.8M | 101.1M | 111.0M | 105.5M | 77.8M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 1.3M | 146.0K | 667.0K | 800.0K | 300.0K |
| Total Non-Current Liabilities | 173.0M | 210.0M | 120.7M | 131.9M | 108.2M |
| Total Liabilities | 362.1M | 401.8M | 254.4M | 240.7M | 199.4M |
| Equity | |||||
| Common Stock | 737.0K | 729.0K | 722.0K | 714.0K | 710.0K |
| Retained Earnings | -628.8M | -525.5M | -338.4M | -379.1M | -230.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 364.1M | 421.4M | 548.6M | 447.9M | 557.1M |
| Key Metrics | |||||
| Total Debt | 109.2M | 117.8M | 127.9M | 116.5M | 79.9M |
| Working Capital | 330.1M | 443.2M | 434.1M | 425.2M | 533.8M |
Balance Sheet Composition
Schrodinger Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -103.3M | -187.1M | 40.7M | -149.2M | -101.2M |
| Depreciation & Amortization | 6.0M | 6.2M | 5.6M | 4.3M | 2.8M |
| Stock-Based Compensation | 43.0M | 49.9M | 47.8M | 39.6M | 26.5M |
| Working Capital Changes | 123.4M | -18.0M | -26.9M | -19.5M | -4.1M |
| Operating Cash Flow | 69.1M | -149.0M | 67.2M | -124.7M | -75.2M |
| Investing Activities | |||||
| Capital Expenditures | -1.4M | -7.3M | -13.4M | -8.0M | -7.2M |
| Acquisitions | 17.7M | 45.7M | 0 | -6.4M | 0 |
| Investment Purchases | -313.0M | -251.3M | -324.7M | -272.1M | -418.5M |
| Investment Sales | 354.6M | 361.8M | 384.0M | 364.7M | 408.5M |
| Investing Cash Flow | 57.9M | 148.8M | 45.8M | 78.2M | -17.2M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | -58.0K | -58.0K | -19.0K | 0 | 0 |
| Financing Cash Flow | -58.0K | 8.6M | -392.0K | 0 | 25.0K |
| Free Cash Flow | 12.5M | -164.7M | -150.1M | -127.7M | -77.8M |
| Net Change in Cash | 127.0M | 8.4M | 112.7M | -46.5M | -92.3M |
Cash Flow Trend
Schrodinger Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
44.39
Forward P/E
-8.54
Price to Book
2.39
Price to Sales
3.40
PEG Ratio
-8.54
Profitability Ratios
Profit Margin
-40.36%
Operating Margin
-19.67%
Return on Equity
-26.29%
Return on Assets
-13.47%
Financial Health
Current Ratio
2.74
Debt to Equity
30.03
Beta
1.62
Per Share Data
EPS (TTM)
$-1.41
Book Value per Share
$4.94
Revenue per Share
$3.48
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SDGR | 870.4M | 44.39 | 2.39 | -26.29% | -40.36% | 30.03 |
| Ge Healthcare | 31.9B | 15.92 | 3.18 | 22.38% | 10.10% | 98.72 |
| Veeva Systems | 26.5B | 29.57 | 3.66 | 13.93% | 28.45% | 1.33 |
| Omnicell | 1.7B | 918.75 | 1.34 | 0.17% | 0.17% | 16.59 |
| Teladoc Health | 1.0B | - | 0.74 | -13.93% | -7.92% | 75.06 |
| Certara | 969.0M | 105.00 | 0.95 | -0.15% | -0.38% | 28.96 |
Financial data is updated regularly. All figures are in the company's reporting currency.






